CCRM, established in 2011, is a global public-private partnership supporting the commercialization of regenerative medicine and cell and gene therapies. With strategic funding, specialized expertise, and CDMO services through OmniaBio Inc., CCRM accelerates new ventures and industry growth. Based in Toronto’s Discovery District, CCRM operates within a premier health innovation hub, connecting with top research institutions and a vast network of students and scientists.